International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.
Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, MA 02114, USA. ckotton@partners.org
Camille N
CN
Kotton
Deepali
D
Kumar
Angela M
AM
Caliendo
Anders
A
Asberg
Sunwen
S
Chou
David R
DR
Snydman
Upton
U
Allen
Atul
A
Humar
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D032921:Consensus; D003245:Consensus Statements as Topic; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D022482:Cytomegalovirus Vaccines; D024882:Drug Resistance, Viral; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007391:International Cooperation; D016377:Organ Transplantation / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D022482:Cytomegalovirus Vaccines; D007166:Immunosuppressive Agents